Form 10-Q/A Amendment No. 1

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

 

FORM 10-Q/A

Amendment No. 1

 

 

 

    x     QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended July 31, 2012

or

 

    ¨     TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from         to         

Commission File Number: 0-28132

 

 

STREAMLINE HEALTH SOLUTIONS, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   31-1455414

(State or other jurisdiction of

incorporation or organization)

  

(I.R.S. Employer

Identification No.)

10200 Alliance Road, Suite 200

Cincinnati, Ohio 45242-4716

(Address of principal executive offices) (Zip Code)

(513) 794-7100

(Registrant’s telephone number, including area code)

 

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  x    No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated filer   ¨    Accelerated filer   ¨
Non-accelerated filer   ¨    Smaller reporting company   x

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ¨    No  x

Number of shares of Registrant’s Common Stock ($.01 par value per share) issued and outstanding, as of September 14, 2012: 12,525,655.

 

 

 

Explanatory Note

The sole purpose of this amendment to our Quarterly Report on Form 10-Q for the period ended July 31, 2012, originally filed with the Securities and Exchange Commission on September 14, 2012, is to furnish Exhibit 101 to the Form 10-Q, which contains the XBRL (eXtensible Business Reporting Language) Interactive Data Files for the financial statements and notes included in Part I, Item 1 of the Form 10-Q. As permitted by Rule 405 of Regulation S-T, Exhibit 101 was required to be furnished within 30 days of the original filing date of the Form 10-Q.

This amendment does not reflect events occurring after the original filing. Except for the foregoing information, this Form 10-Q/A continues to speak as of the date of the original filing and the Company has not otherwise updated disclosures contained therein or herein to reflect events that occurred at a later date.

 

Item 6. EXHIBITS

See Index to Exhibits.

 

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

      STREAMLINE HEALTH SOLUTIONS, INC.
DATE:                 October 12, 2012                     By:  

/s/ Robert E. Watson

     

Robert E. Watson

Chief Executive Officer

DATE:                 October 12, 2012                     By:  

/s/ Stephen H. Murdock

     

Stephen H. Murdock

Chief Financial Officer

 

3

INDEX TO EXHIBITS

 

Exhibit

No.

   

Description of Exhibit

       
  31.1    Certification by Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.      * * 
  31.2    Certification by Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.      * * 
  32.1    Certification by Chief Executive Officer pursuant to U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.      * * 
  32.2    Certification by Chief Financial Officer pursuant to U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.      * * 
101.INS    XBRL Instance Document      * ** 
101.SCH    XBRL Taxonomy Extension Schema Document      * ** 
101.CAL    XBRL Taxonomy Extension Calculation Linkbase Document      * ** 
101.LAB    XBRL Taxonomy Extension Label Linkbase Document      * ** 
101.PRE    XBRL Taxonomy Extension Presentation Linkbase Document      * ** 
101.DEF    XBRL Taxonomy Extension Definition Linkbase Document      * ** 

 

** Previously filed as an exhibit to the Registrant’s Quarterly Report on Form 10-Q for the quarterly period ended July 31, 2012.
*** Furnished herein

 

4